trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Only a small proportion of men with early stage prostate cancer die from the disease within 10 to 15 years of diagnosis.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that only a small proportion of men with early stage prostate cancer die from the disease within 10 to 15 years of diagnosis?

Yes. Clinical evidence confirms that only a small proportion of men diagnosed with early-stage prostate cancer die from the disease over a 10- to 15-year period.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked

The analysis

The retrieved population-based studies and cohort analyses consistently demonstrate extremely high long-term survival rates (often exceeding 90-99%) for localized or early-stage prostate cancer, supporting the claim that very few men die from the disease within 10 to 15 years of diagnosis.

Evidence for · 3
2026
Get citation
D, M., L, W., T, S., S, T., C, W., S, S., S, H., M, L., R, C., AJ, T., C, C., CA, R., D, E., M, K., A, M., A, C., S, R., M, C., & K, S. (2026). Prostate Cancer Incidence, Mortality, and Survival in Switzerland.. doi.org. https://doi.org/10.1001/jamanetworkopen.2026.8289

See more details
More for · 2
2026
Get citation
T, S., C, O., & K, S. (2026). Clinical Significance of Pathological Lymph Node Status in Prostate Cancer Patients Undergoing Radical Prostatectomy: A 25-Year Institutional Cohort Study.. doi.org. https://doi.org/10.1155/aiu/1399937

2026
Get citation
I, H., TÅ, M., SD, F., S, M., & K, A. (2026). Does active surveillance prior to radical prostatectomy increase the risk of adverse pathological findings or postoperative prostate cancer treatment?. doi.org. https://doi.org/10.1007/s00345-026-06617-5

What does the evidence say?

The retrieved population-based studies and cohort analyses consistently demonstrate extremely high long-term survival rates (often exceeding 90-99%) for localized or early-stage prostate cancer, supporting the claim that very few men die from the disease within 10 to 15 years of diagnosis.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work